Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for emergence agitation after pediatric root canal treatment under combined anesthesia
ChiCTR2300075012Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Emergence agitation (EA) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Emergence agitation score. Started Aug 2023; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2300075012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075012.